Arcutis Biotherapeutics, Inc.
ARQT
Peringkat dalam Saham
#4366
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Harga Saham
$28.54
Terakhir disinkronkan: 2026-10-16
Kapitalisasi Pasar
$3.59B
Perubahan (1 hari)
-1.94%
Perubahan (1 tahun)
36.66%
Negara
US
Perdagangan Arcutis Biotherapeutics, Inc. (ARQT)
Kategori
Healthcare
EPS untuk Arcutis Biotherapeutics, Inc. (ARQT)
EPS per June 2026 TTM: $0.22
Menurut laporan keuangan terbaru dan harga saham Arcutis Biotherapeutics, Inc., EPS perusahaan saat ini (TTM) adalah $0.22. Pada akhir 2023, perusahaan memiliki EPS sebesar $-3.78 penurunan dibandingkan dengan EPS tahun 2022 sebesar $-5.66.
Riwayat EPS untuk Arcutis Biotherapeutics, Inc. dari 2017 hingga 2026
EPS di akhir setiap tahun
| Tahun | EPS | Mengubah |
|---|---|---|
| 2026 (TTM) | $0.22 | -118.97% |
| 2024 | $-1.16 | -69.31% |
| 2023 | $-3.78 | -33.22% |
| 2022 | $-5.66 | 35.73% |
| 2021 | $-4.17 | 9.74% |
| 2020 | $-3.80 | 245.45% |
| 2019 | $-1.10 | 107.55% |
| 2018 | $-0.53 | -88.75% |
| 2017 | $-4.71 | 0.00% |
EPS untuk perusahaan sejenis atau pesaing
| Perusahaan | EPS | Perbedaan EPS | Negara |
|---|---|---|---|
| $17.32 | 7,772.73% |
US
|
|
| $-7.98 | -3,727.27% |
US
|
|
| $-5.29 | -2,504.55% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 12,509.09% |
NL
|
